LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

Search

West Pharmaceutical Services Inc

Cerrado

SectorSanidad

277.46 0.35

Resumen

Variación precio

24h

Actual

Mínimo

272.95

Máximo

277.77

Métricas clave

By Trading Economics

Ingresos

8.2M

140M

Ventas

38M

804M

P/B

Media del Sector

40.651

79.874

BPA

1.96

Rentabilidad por dividendo

0.31

Margen de beneficios

17.406

Empleados

10,600

EBITDA

19M

217M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+26.13% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.31%

2.31%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-56M

20B

Apertura anterior

277.11

Cierre anterior

277.46

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

165 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

West Pharmaceutical Services Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

28 nov 2025, 15:29 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

China's Jiangxi Copper Rejected by SolGold in $1 Billion Takeover Approach

28 nov 2025, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

28 nov 2025, 19:59 UTC

Charlas de Mercado

Oil Futures Settle Lower in Slow Black Friday Trade -- Market Talk

28 nov 2025, 19:47 UTC

Charlas de Mercado

U.S. Natural Gas Lifted By Cold Weather Outlook -- Market Talk

28 nov 2025, 18:16 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

28 nov 2025, 18:16 UTC

Charlas de Mercado

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

28 nov 2025, 18:08 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

28 nov 2025, 18:08 UTC

Charlas de Mercado

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

28 nov 2025, 17:48 UTC

Charlas de Mercado

Bank of Canada May Revise Up Inflation Projections After GDP Data -- Market Talk

28 nov 2025, 17:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

28 nov 2025, 16:50 UTC

Adquisiciones, fusiones, absorciones

Week's Best: Sieg's Stature at Citi Grows -- Barrons.com

28 nov 2025, 15:51 UTC

Charlas de Mercado

Canada Household Spending Edges Lower -- Market Talk

28 nov 2025, 15:33 UTC

Charlas de Mercado

Crude Futures Gain as U.S. Market Reopens -- Market Talk

28 nov 2025, 15:21 UTC

Charlas de Mercado

Gold Rises on U.S. Rate-Cut Bets After CME Outage -- Market Talk

28 nov 2025, 15:13 UTC

Charlas de Mercado

Dollar Recovers Slightly as Investors Already Price in Fed Rate Cut -- Market Talk

28 nov 2025, 15:11 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

28 nov 2025, 15:11 UTC

Charlas de Mercado

Canadian National Railway Showing Positive Trend Going Into 2026 -- Market Talk

28 nov 2025, 14:51 UTC

Charlas de Mercado

Canada GDP Report Masks Fragile State of Economy -- Market Talk

28 nov 2025, 14:41 UTC

Charlas de Mercado

Canada's GDP Level Pulled Higher by 'Eye-Opening' Revisions -- Market Talk

28 nov 2025, 14:37 UTC

Charlas de Mercado

U.S. Natural Gas Futures Rise As Temperatures Drop -- Market Talk

28 nov 2025, 14:33 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

28 nov 2025, 14:33 UTC

Charlas de Mercado

Steep Import Drop Fuels Surprise Lift in Canada GDP -- Market Talk

28 nov 2025, 14:20 UTC

Charlas de Mercado

Too Much Noise in Canada's Surprise 3Q GDP Gain -- Market Talk

28 nov 2025, 14:10 UTC

Charlas de Mercado

Canadian Nowcast Came Closest to Predicting Surprise 3Q Strength -- Market Talk

28 nov 2025, 13:39 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

28 nov 2025, 13:39 UTC

Charlas de Mercado

Canada Trade Data Could Face Larger-Than-Normal Revisions -- Market Talk

28 nov 2025, 13:36 UTC

Charlas de Mercado

Canada's Economy Expands More Than Expected -- Market Talk

28 nov 2025, 13:29 UTC

Charlas de Mercado

CME Outage Sowing Chaos Across Markets, Trade Nations Says -- Market Talk

28 nov 2025, 13:27 UTC

Charlas de Mercado

Russia-Ukraine Peace Efforts to Have Little Impact on Oil Fundamentals -- Market Talk

28 nov 2025, 13:19 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

Comparación entre iguales

Cambio de precio

West Pharmaceutical Services Inc previsión

Precio Objetivo

By TipRanks

26.13% repunte

Estimación a 12 Meses

Media 349.56 USD  26.13%

Máximo 375 USD

Mínimo 311 USD

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para West Pharmaceutical Services Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

11 ratings

10

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

213.26 / 219.27Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

165 / 374 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat